Active Syk contributes to CLL cell survival by regulating Mcl1 expression, and this was demonstrated using fostamatinib and siRNA knockdown of Syk expression [103, 162]. The gene discussed is SYK; the disease is B-cell chronic lymphocytic leukemia.